Ryan J. Rafferty

Dr. Ryan J. Rafferty serves as Associate Professor in Chemistry at Kansas State University and Interim Director of the Johnson Cancer Research Center (JCRC), with leadership roles spanning Assistant Director (2014-2020) to current Interim Directorship (2020-Present). His research bridges synthetic chemistry and oncology to develop novel brain cancer therapeutics.

Education

• Ph.D. in Synthetic Organic Chemistry, Colorado State University (2005-2011)
• M.S. in Biochemistry, University of Northern Colorado (2001-2004)
• B.S. in Biology, University of Northern Colorado (2000-2002)
• B.A. in Chemistry (Biochemistry Emphasis), University of Northern Colorado (1996-2000)

His lab pioneers blood-brain barrier penetration strategies for brain tumor treatment through chemophysical property mapping, while developing natural product-based cytotoxic agents that exploit differential cellular processes in cancer cells to minimize off-target effects. This multidisciplinary work integrates synthetic organic chemistry, medicinal chemistry, and chemical biology to advance personalized cancer therapeutics.

Publication analysis reveals consistent focus on complex natural product synthesis (hapalindoles, ambiguines) and methodological innovation for bioactive compounds. His work demonstrates strategic progression from reagent development (2009 proline synthesis) to complex alkaloid frameworks (2011-2014), targeting oncology applications through molecular design.

As JCRC Interim Director, Dr. Rafferty oversees cancer research initiatives while mentoring students in chemistry-biology interface techniques. His leadership connects fundamental chemical research with translational cancer applications through institutional resources like the JCRC's Conquest magazine feature (2017).